Literature DB >> 33730321

Genetic Analysis of UGT1A1 Polymorphisms Using Preserved Dried Umbilical Cord for Assessing the Potential of Neonatal Jaundice as a Risk Factor for Autism Spectrum Disorder in Children.

Tomoko Horinouchi1, Kaori Maeyama1,2, Masashi Nagai1,3, Masami Mizobuchi4, Yasuko Takagi5, Yuka Okada6, Takeshi Kato7, Mio Nishimura8, Yoko Kawasaki8, Mieko Yoshioka5, Satoshi Takada5, Hisayuki Matsumoto9, Yuji Nakamachi9, Jun Saegusa9, Sachiyo Fukushima1, Kazumichi Fujioka1, Kazumi Tomioka1, Hiroaki Nagase1, Kandai Nozu1, Kazumoto Iijima1, Noriyuki Nishimura10.   

Abstract

Neonatal jaundice has been suggested as a perinatal risk factor for autism spectrum disorder (ASD). We examined UGT1A1 polymorphisms to assess the potential of neonatal jaundice as a risk factor for ASD in children by using DNA extracted from preserved umbilical cord. In total, 79 children with ASD were genotyped for UGT1A1*28 (c.-41-40dup), UGT1A1*6 (c.211 G > A), and UGT1A1*27 (c.686 C > A). The allele frequency of UGT1A1*6 (OR = 1.34, p = 0.26) and UGT1A1*28 (OR = 0.80, p = 0.54) and the prevalence of UGT1A1*28/*6 diplotypes did not differ significantly from those in the control population. No UGT1A1*27 allele was detected in the subjects. ASD symptom assessment scores were not associated with UGT1A1*28/*6/*27 genotypes or UGT1A1*28/*6 diplotypes. These results suggest that neonatal jaundice is not significantly associated with ASD.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autism spectrum disorder; Dried umbilical cord; Neonatal jaundice; Polymorphism; UGT1A1

Mesh:

Substances:

Year:  2021        PMID: 33730321     DOI: 10.1007/s10803-021-04941-w

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  32 in total

Review 1.  Neonatal hyperbilirubinemia.

Authors:  P A Dennery; D S Seidman; D K Stevenson
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

Review 2.  Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.

Authors:  Sanjiv B Amin; Tristram Smith; Hongyue Wang
Journal:  J Autism Dev Disord       Date:  2011-11

3.  Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder.

Authors:  Elizabeth Hisle-Gorman; Apryl Susi; Theophil Stokes; Gregory Gorman; Christine Erdie-Lalena; Cade M Nylund
Journal:  Pediatr Res       Date:  2018-04-18       Impact factor: 3.756

4.  Neonatal hyperbilirubinemia and risk of autism spectrum disorders.

Authors:  Lisa A Croen; Cathleen K Yoshida; Roxana Odouli; Thomas B Newman
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

5.  Comparison of the Kyoto Scale of Psychological Development 2001 with the parent-rated Kinder Infant Development Scale (KIDS).

Authors:  Sayaka Aoki; Keiji Hashimoto; Natsuha Ikeda; Makoto Takekoh; Takeo Fujiwara; Naho Morisaki; Hidetoshi Mezawa; Yoshiyuki Tachibana; Yukihiro Ohya
Journal:  Brain Dev       Date:  2015-11-21       Impact factor: 1.961

6.  Prenatal and perinatal risk factors in a twin study of autism spectrum disorders.

Authors:  Wendy Froehlich-Santino; Amalia Londono Tobon; Sue Cleveland; Andrea Torres; Jennifer Phillips; Brianne Cohen; Tiffany Torigoe; Janet Miller; Angie Fedele; Jack Collins; Karen Smith; Linda Lotspeich; Lisa A Croen; Sally Ozonoff; Clara Lajonchere; Judith K Grether; Ruth O'Hara; Joachim Hallmayer
Journal:  J Psychiatr Res       Date:  2014-03-29       Impact factor: 4.791

7.  Neonatal jaundice in association with autism spectrum disorder and developmental disorder.

Authors:  Christina Cordero; Laura A Schieve; Lisa A Croen; Stephanie M Engel; Anna Maria Siega-Riz; Amy H Herring; Catherine J Vladutiu; Carl J Seashore; Julie L Daniels
Journal:  J Perinatol       Date:  2019-08-06       Impact factor: 2.521

8.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

9.  Comparison of effects of UGT1A1*6 and UGT1A1*28 on irinotecan-induced adverse reactions in the Japanese population: analysis of the Biobank Japan Project.

Authors:  Keiko Hikino; Takeshi Ozeki; Masaru Koido; Chikashi Terao; Yoichiro Kamatani; Yoshinori Murakami; Michiaki Kubo; Taisei Mushiroda
Journal:  J Hum Genet       Date:  2019-10-04       Impact factor: 3.172

10.  Identification of common genetic risk variants for autism spectrum disorder.

Authors:  Jakob Grove; Stephan Ripke; Thomas D Als; Manuel Mattheisen; Raymond K Walters; Hyejung Won; Jonatan Pallesen; Esben Agerbo; Ole A Andreassen; Richard Anney; Swapnil Awashti; Rich Belliveau; Francesco Bettella; Joseph D Buxbaum; Jonas Bybjerg-Grauholm; Marie Bækvad-Hansen; Felecia Cerrato; Kimberly Chambert; Jane H Christensen; Claire Churchhouse; Karin Dellenvall; Ditte Demontis; Silvia De Rubeis; Bernie Devlin; Srdjan Djurovic; Ashley L Dumont; Jacqueline I Goldstein; Christine S Hansen; Mads Engel Hauberg; Mads V Hollegaard; Sigrun Hope; Daniel P Howrigan; Hailiang Huang; Christina M Hultman; Lambertus Klei; Julian Maller; Joanna Martin; Alicia R Martin; Jennifer L Moran; Mette Nyegaard; Terje Nærland; Duncan S Palmer; Aarno Palotie; Carsten Bøcker Pedersen; Marianne Giørtz Pedersen; Timothy dPoterba; Jesper Buchhave Poulsen; Beate St Pourcain; Per Qvist; Karola Rehnström; Abraham Reichenberg; Jennifer Reichert; Elise B Robinson; Kathryn Roeder; Panos Roussos; Evald Saemundsen; Sven Sandin; F Kyle Satterstrom; George Davey Smith; Hreinn Stefansson; Stacy Steinberg; Christine R Stevens; Patrick F Sullivan; Patrick Turley; G Bragi Walters; Xinyi Xu; Kari Stefansson; Daniel H Geschwind; Merete Nordentoft; David M Hougaard; Thomas Werge; Ole Mors; Preben Bo Mortensen; Benjamin M Neale; Mark J Daly; Anders D Børglum
Journal:  Nat Genet       Date:  2019-02-25       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.